{"id":"https://openalex.org/W1541535305","doi":"https://doi.org/10.18632/oncotarget.438","title":"\u201cPicolog,\u201d a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced LymphomaIn Vivo","display_name":"\u201cPicolog,\u201d a Synthetically-Available Bryostatin Analog, Inhibits Growth of MYC-Induced LymphomaIn Vivo","publication_year":2012,"publication_date":"2012-01-31","ids":{"openalex":"https://openalex.org/W1541535305","doi":"https://doi.org/10.18632/oncotarget.438","mag":"1541535305","pmid":"https://pubmed.ncbi.nlm.nih.gov/22308267","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3292892"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.438","doi":"https://doi.org/10.18632/oncotarget.438","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.438","pdf_url":"https://www.oncotarget.com/article/438/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.oncotarget.com/article/438/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044085338","display_name":"Brian A. DeChristopher","orcid":"https://orcid.org/0000-0002-4833-7302","observed_orcids":["https://orcid.org/0000-0002-4833-7302"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Brian A. DeChristopher","raw_affiliation_strings":["Departments of Chemistry and Chemical and Systems Biology, Stanford University, Stanford, CA 94305-5080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Chemistry and Chemical and Systems Biology, Stanford University, Stanford, CA 94305-5080","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028169162","display_name":"Alice C. Fan","orcid":"https://orcid.org/0000-0002-4813-5444","observed_orcids":["https://orcid.org/0000-0002-4813-5444"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alice C. Fan","raw_affiliation_strings":["Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010630509","display_name":"Dean W. Felsher","orcid":"https://orcid.org/0000-0003-2496-523X","observed_orcids":["https://orcid.org/0000-0003-2496-523X"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dean W. Felsher","raw_affiliation_strings":["Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060002438","display_name":"Paul A. Wender","orcid":"https://orcid.org/0000-0001-6319-2829","observed_orcids":["https://orcid.org/0000-0001-6319-2829"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul A. Wender","raw_affiliation_strings":["Departments of Chemistry and Chemical and Systems Biology, Stanford University, Stanford, CA 94305-5080"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Chemistry and Chemical and Systems Biology, Stanford University, Stanford, CA 94305-5080","institution_ids":["https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028169162","https://openalex.org/A5044085338"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":2.4872,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.88295075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"1","first_page":"58","last_page":"66"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.23999999463558197,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.23999999463558197,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.14990000426769257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.12710000574588776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bryostatin-1","display_name":"bryostatin 1","score":0.921999990940094},{"id":"https://openalex.org/keywords/protein-kinase-c-activation","display_name":"protein kinase C activation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pkc-pathway","display_name":"PKC pathway","score":0.6000000238418579},{"id":"https://openalex.org/keywords/in-vivo-antitumor-activity","display_name":"in vivo antitumor activity","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2910806222","wikidata":"https://www.wikidata.org/wiki/Q4981136","display_name":"Bryostatin 1","level":4,"score":0.9447207450866699},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7850649356842041},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5398129820823669},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.5322442054748535},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.49726513028144836},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.43537867069244385},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42466479539871216},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.420584499835968},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4188547730445862},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32234346866607666},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2849854826927185},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20442581176757812},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18440106511116028},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002471","descriptor_name":"Cell Transformation, Neoplastic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016259","descriptor_name":"Genes, myc","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054713","descriptor_name":"Bryostatins","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D054713","descriptor_name":"Bryostatins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054713","descriptor_name":"Bryostatins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.18632/oncotarget.438","doi":"https://doi.org/10.18632/oncotarget.438","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.438","pdf_url":"https://www.oncotarget.com/article/438/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3292892","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3292892","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:22308267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22308267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.271.9788","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.271.9788","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/34/80/Oncotarget_2012_Feb_2_3(1)_58-66.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.438","doi":"https://doi.org/10.18632/oncotarget.438","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.438","pdf_url":"https://www.oncotarget.com/article/438/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1121106320","display_name":null,"funder_award_id":"105102","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G117567","display_name":"In Vivo Cellular and Molecular Imaging Center@Stanford","funder_award_id":"P50CA114747","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2517722474","display_name":"Molecular and Cellular Basis of Oncogene Addiction","funder_award_id":"R01CA105102","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G292495003","display_name":"Nanoscale analysis of proteomic response to novel targeted therapies for lymphoma","funder_award_id":"K23CA140722","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3488207546","display_name":"Synthetic Studies Related to Cancer Research/Treatment","funder_award_id":"R37CA031845","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4404722530","display_name":"Computational Modeling of Cancer Biology","funder_award_id":"U56CA112973","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5533922016","display_name":"Clinical and Laboratory Studies of Malignant Lymphomas","funder_award_id":"P01CA034233","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7833855070","display_name":"MYC's Role in the Initiation and Maintenance of Cancer","funder_award_id":"R01CA089305","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000323393","display_name":null,"funder_award_id":"CA31845","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000895622","display_name":"Synthetic Studies Related to Cancer Research/Treatment","funder_award_id":"R01CA031845","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306133","display_name":"Burroughs Wellcome Fund","ror":"https://ror.org/01d35cw23"},{"id":"https://openalex.org/F4320306271","display_name":"Damon Runyon Cancer Research Foundation","ror":"https://ror.org/01gd7b947"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1541535305.pdf","grobid_xml":"https://content.openalex.org/works/W1541535305.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W95673823","https://openalex.org/W1567188325","https://openalex.org/W1570282298","https://openalex.org/W1967360804","https://openalex.org/W1970279665","https://openalex.org/W1976943819","https://openalex.org/W1979298568","https://openalex.org/W1982884889","https://openalex.org/W1983338160","https://openalex.org/W1983706370","https://openalex.org/W1987984681","https://openalex.org/W1991502041","https://openalex.org/W1996339149","https://openalex.org/W2004380135","https://openalex.org/W2005512248","https://openalex.org/W2007650429","https://openalex.org/W2014624348","https://openalex.org/W2017421424","https://openalex.org/W2020382107","https://openalex.org/W2025644461","https://openalex.org/W2027656346","https://openalex.org/W2032220572","https://openalex.org/W2034699914","https://openalex.org/W2038250293","https://openalex.org/W2055264554","https://openalex.org/W2062550680","https://openalex.org/W2065519715","https://openalex.org/W2069539795","https://openalex.org/W2069710540","https://openalex.org/W2071039401","https://openalex.org/W2079598920","https://openalex.org/W2083680588","https://openalex.org/W2087091972","https://openalex.org/W2090429649","https://openalex.org/W2090999558","https://openalex.org/W2092052198","https://openalex.org/W2109033521","https://openalex.org/W2114893459","https://openalex.org/W2117029515","https://openalex.org/W2121793799","https://openalex.org/W2124484803","https://openalex.org/W2131568271","https://openalex.org/W2140105413","https://openalex.org/W2153597111","https://openalex.org/W2156060934","https://openalex.org/W2162981791","https://openalex.org/W2166974430","https://openalex.org/W2275165869","https://openalex.org/W2506353217","https://openalex.org/W2573633935","https://openalex.org/W2949088814","https://openalex.org/W2950215543","https://openalex.org/W2951264101","https://openalex.org/W3005434895","https://openalex.org/W4234505122"],"related_works":["https://openalex.org/W1949645215","https://openalex.org/W1983706370","https://openalex.org/W1996339149","https://openalex.org/W1574703444","https://openalex.org/W2055213792","https://openalex.org/W2066223233","https://openalex.org/W1944964332","https://openalex.org/W2119801401","https://openalex.org/W2148378566","https://openalex.org/W21899865"],"abstract_inverted_index":{"Brian":[0],"A.":[1,16,68],"DeChristopher":[2],"1,*":[3],",":[4,9,14],"Alice":[5],"C.":[6],"Fan":[7],"2,*":[8],"Dean":[10,73],"W.":[11,74],"Felsher":[12],"2":[13,33],"Paul":[15,67],"Wender":[17,69],"1":[18,19,81,192],"Departments":[20],"of":[21,35,40,110,134,143,150,169,199,203,226],"Chemistry":[22],"and":[23,25,112,182,228],"Chemical":[24],"Systems":[26],"Biology,":[27],"Stanford":[28,37],"University,":[29],"Stanford,":[30,42],"CA":[31,43],"94305-5080":[32],"Division":[34],"Oncology,":[36],"University":[38],"School":[39],"Medicine,":[41],"94305":[44],"*":[45],"Denotes":[46],"equal":[47],"contribution":[48],"Received:":[49],"January":[50],"22,":[51],"2012;":[52,56,60],"Accepted:":[53],"February":[54,58],"2,":[55,59],"Published:":[57],"Keywords:":[61],"bryostatin,":[62,129],"picolog,":[63,217],"lymphoma,":[64],"PKC":[65,164,170],"Correspondence:":[66],"Ph.D.,":[70],"email:":[71,76],"//":[72,77,78],"Felsher,":[75],"Abstract":[79],"Bryostatin":[80],"is":[82,148,218],"a":[83,104,219],"naturally":[84],"occurring":[85],"complex":[86],"macrolide":[87],"with":[88],"potent":[89,178],"anti-neoplastic":[90],"activity.":[91,173],"However,":[92],"its":[93],"extremely":[94],"low":[95],"natural":[96],"occurrence":[97],"has":[98],"impeded":[99],"clinical":[100],"advancement.":[101],"We":[102,206],"developed":[103],"strategy":[105],"directed":[106],"at":[107,179,185],"the":[108,163,167,197,208,214,224],"design":[109],"simplified":[111],"synthetically":[113],"more":[114],"accessible":[115],"bryostatin":[116,215],"analogs.":[117],"Our":[118],"lead":[119],"analog,":[120,216],"\u201cpicolog\u201d,":[121],"can":[122],"be":[123],"step-economically":[124],"produced.":[125],"Picolog,":[126],"compared":[127],"to":[128,191],"exhibited":[130],"superior":[131],"growth":[132],"inhibition":[133,168],"MYC-induced":[135,204],"lymphoma":[136],"in":[137,162,194,210],"vitro":[138],".":[139],"A":[140,152],"key":[141],"mechanism":[142],"picolog\u2019s":[144,172],"(and":[145],"bryostatin\u2019s)":[146],"activity":[147],"activation":[149],"PKC.":[151],"novel":[153],"nano-immunoassay":[154],"(NIA)":[155],"revealed":[156],"that":[157,213],"picolog":[158,175],"treatment":[159,198,225],"increased":[160],"phospho-MEK2":[161],"pathway.":[165],"Moreover,":[166],"abrogated":[171],"Finally,":[174],"was":[176],"highly":[177],"100":[180,189],"micrograms/kg":[181,190],"well":[183],"tolerated":[184],"doses":[186],"ranging":[187],"from":[188],"milligram/kg":[193],"vivo":[195,211],"for":[196,223],"our":[200],"aggressive":[201],"model":[202],"lymphoma.":[205],"provide":[207],"first":[209],"validation":[212],"potential":[220],"therapeutic":[221],"agent":[222],"cancer":[227],"other":[229],"diseases.":[230]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}